The main enzyme responsible for replicating the DNA methylation pattern is DNMT1. This enzyme shows preference for hemimethylated DNA and is therefore believed to faithfully copy the DNA methylation pattern (6). Multiple mechanisms have been proposed to coordinate the inheritance of DNA methylation patterns with DNA replication. First, DNMT1 expression is regulated with the cell cycle (7, 8) and it is upregulated by protooncogenes Ras and Jun (9, 10) (11) Fos (12) and T antigen (13). Second, DNMT1 is localized to the replication fork (14) and is associated with (18) or p16 (19), leading to retreat from the cell cycle. A conditional knock out of murine dnmt1 gene was also shown to reduce the rate of cell division (5), but it is still unclear whether inhibition of DNMT1 leads to a change in cell cycle kinetics similar to DNA damage response checkpoints.
The main enzyme responsible for replicating the DNA methylation pattern is DNMT1. This enzyme shows preference for hemimethylated DNA and is therefore believed to faithfully copy the DNA methylation pattern (6) . Multiple mechanisms have been proposed to coordinate the inheritance of DNA methylation patterns with 4 DNA replication is believed to have evolved to guarantee concordant replication of DNA and its methylation pattern. Previous studies have shown that inhibition of DNMT1 can lead to inhibition of initiation of DNA replication (17) but it is not clear whether this response is a consequence of induction of tumor suppressor genes such as p21 (18) or p16 (19) , leading to retreat from the cell cycle. A conditional knock out of murine dnmt1 gene was also shown to reduce the rate of cell division (5) , but it is still unclear whether inhibition of DNMT1 leads to a change in cell cycle kinetics similar to DNA damage response checkpoints.
Multiple mechanisms have been established to guard the integrity of the genome in response to DNA damage. For example, two parallel, cooperating mechanisms, both regulated by ATM, jointly contribute to the rapid and transient inhibition of firing of origins of DNA replication in response to ionizing radiation (20) (21) (22) . This stalling of DNA synthesis is required to prevent genetic instability by coordinating replication and repair. We reasoned that similar mechanisms guard the integrity of epigenomic information in response to a disruption in the DNA methylation machinery.
In this paper we test this hypothesis by determining the response of human cell lines to a knockdown of DNMT1 mRNA, encoding the enzyme responsible for the replication of the DNA methylation pattern. Our data suggests that cells respond to this epigenomic stress by an intra S phase arrest of DNA synthesis as well as by inducing a large number of stress response genes. The slow down in DNA synthesis during S protects the DNA from a global loss of the methylation pattern. This mechanism is not triggered by 5-aza-CdR, which causes an extensive loss of DNA methylation. The phosphorothioate oligodeoxynucleotides used in this study were MG88 (human DNMT1 antisense oligonucleotide) and its mismatch control MG208, which has a 6 base pair difference from MG88 (19) . Oligonucleotides were transfected into cells DNA Methyltransferase Activity Assay and Western blot analysis-To determine the level of cellular DNA methyltransferase activity, nuclear extracts were prepared and DNA methyltransferase activity was assayed as described previously (8) . For
MATERIALS AND METHODS

Cell
Western blot analysis of DNMT1, 50 µg nuclear protein was fractionated on a 5%
SDS-polyacrylamide gel, transferred to polyvinylidene difluoride membrane and reacted with the polyclonal anti DNMT1 antibody (New England Biolabs) at a dilution of 1:2000 in the presence of 0.05% Tween and 5% milk, and was then reacted with anti rabbit IgG (Sigma) at a dilution of 1:5000. The amount of total protein per lane was determined by Amido black staining (23) . The intensity of DNMT1 and total protein signal was measured by scanning densitometry and the ratio of DNMT1/total nuclear protein was calculated.
RT-PCR-Total RNA was extracted using the standard guanidium isothiocyanate method (24) . cDNA was synthesized in a 20-µl reaction volume containing 2 µg of total RNA, 40 u MMuLV reverse transcriptase (MBI), 5µM random primer (Roche), 1 mM of each of the four deoxynucleotide triphosphates and 40 unit RNase inhibitor (Roche). mRNA was denatured for 5 min at 70°C, the random primers were annealed for 10 min at 25°C, and mRNA was reverse transcribed for 1 hr at 37°C. The reverse transcriptase was heat-inactivated for 10 min at 70°C and the products were stored at -20°C until use. 72°C for 1min; for MAGEB2, BIK and SSX2, first cycle 94°C for 30 sec, 62°C for   30 sec, 72°C for 30 sec, second cycle 94°C for 30 sec, 60°C for 30 sec, 72°C for 30   sec, and 30 cycles of 94°C for 30 sec, 58°C for 30 sec, 72°C for 30 sec. The numbers of cycles were selected and tested so that the PCR amplification remained in the linear phase. 10ml of the PCR products were applied on a 1.2% agarose gel and visualized by ethidium bromide staining. Densitometric analysis was performed using Scion Imaging Software (Scion Inc., Frederick, MD).
Competitive PCR for Quantification of DNMT1 mRNA Levels-Total RNA (2µg) was reverse transcribed as described above in the presence of 12.5 µCi of 9 performed as described previously (25) . The methylation status of the p16 gene was determined by methylation specific PCR (26) as modified by Palmisano et al., (27) . Flow cytometry analysis of 5-methyl-cytosine staining-Global DNA methylation was evaluated by staining the cells with specific monoclonal antibody against 5-methylcytidine using the protocol described previously (28) (30) . After the last washing, the cells were resuspended in PBS containing 50 µg/ml propidium iodide and 10 µg/ml RNase A for 30 min at RT, and then analyzed with FACScan (BD Biosceince) for both FITC and PI fluorescence.
RESULTS
Knockdown of DNMT1 mRNA by the DNMT1 antisense oligonucleotide MG88 -DNMT1 activity is physically and temporally associated with the DNA replication machinery. The absence of DNMT1 from the replication fork could potentially lead to an epigenomic catastrophe. We have previously proposed that the coordination of DNMT1 expression and DNA replication evolved as a mechanism to protect the coordinate inheritance of genetic and epigenetic information (31, 32) . To test this hypothesis we determined the cellular response to a knockdown of DNMT1 protein.
We took advantage of a previously described antisense oligonucleotide, which specifically knocks down DNMT1 mRNA (19) MG88, and its mismatch control MG208 (see Fig. 1A for sequence and alignment with human and mouse DNMT1 mRNA antibody (Fig. 1E) . Quantification of the signal by densitometry reveals 85% reduction in protein levels. Inhibition of DNMT1 mRNA by MG88 was also confirmed in a gene array expression analysis presented in Table 2 . These results suggest that the intra S phase arrest is not correlated to the degree of inhibition of DNA methylation per se. Our data is consistent with the hypothesis that the intra S phase arrest following DNMT1 knock down is a response to a reduction in the availability of DNMT1 in the replication fork rather than DNA demethylation. We have previously observed that hemimethylated inhibitors of DNMT1 that inhibit DNA replication also cause only limited demethyation of DNA (33) .
Intra
Comparison of the kinetics of demethylation of the tumor suppressor p16 following DNMT1 knockdown by MG88 and 5-azaCdR trapping of DNMT1.
We addressed the question of whether this difference in the kinetics of global DNA demethylation between 5-azaCdR and DNMT1 antisense oligonucleotides is also observed when specific genes are examined. We focused on the methylated tumor suppressor gene p16 in the human bladder carcinoma cell line T24, since there is no well documented example of a methylated gene in A549 cells that is activated by pharmacological demethylation. The p16 gene is demethylated in response to both 5-azaCdR (38) and
We first verified that the DNMT1 antisense-triggered intra S phase arrest demonstrated above in A549 cells ( We then determined the pattern of methylation of the p16 gene following either DNMT1 antisense or 5-aza-CdR treatments. The methylation pattern of the 5' exon of p16 was studied by methylation specific-PCR that was previously described (26) ( Fig. 6D and E) . The results of this analysis show a dramatic difference in the kinetics of demethylation between MG88 (Fig. 6D ) and 5-aza-CdR (Fig. 6E ) treated cells. While p16 is significantly demethylated 24 hours after initiation of 5-aza-CdR treatment and is completely demethylated after 96 hours (Fig. 6E ), p16 remains fully methylated 48 hours after MG88 treatment at the peak of the intra-S phase DNA replication arrest (Fig. 6D) . Demethylation initiates only at 72 hours. The mechanism of this demethylation is unclear since passive demethylation requires DNA replication in the absence of DNA methyltransferase, while DNA replication is inhibited in T24 cells following MG88 treatment. It is possible that the demethylation of p16 is caused by an active demethylation mechanism or it might result from residual replication in the absence of DNMT1.
In summary, our data reveals that demethylation is delayed when DNA synthesis is (Fig. 7) . This profile of induction is consistent with a methylationindependent mechanism, which is also supported by the induction of BIK after DNMT1 knockdown before any significant global demethylation is observed (two fold induction 24 h after antisense treatment). BIK and other genes induced by a methylation independent mechanism were also induced by the deacetylase inhibitors Trichostatin A (39) and n-butyrate (41). In accordance with previous studies in colorectal cancer (39) , our data shows both methylation dependent and independent induction by 5-aza-CdR in A549 cells (MAGEB2, SSX2, and BIK, respectively).
Based on the data presented above we predicted that in contrast to the response to 5- We compared the normalized gene expression profile of the two treatment groups.
255 (2.1%) genes out of 12,000 genes were upregulated, while there were just 23 (0.19%) genes that were down-regulated. The experiment was repeated with similar results. DNMT1 expression was 75% downregulated in two experiments, which is an internal validation of our gene expression analysis and antisense treatment. The results are presented in Table 2 . Only genes induced in both experiments are included. Amongst the genes that were induced, we did not identify genes that were previously characterized to be silenced by methylation such as SSX2 and MAGEB2.
These two genes were shown to be induced with 5-aza-CdR, but were not induced following DNMT1 knockdown (Figure 7 and 8 ). However, a distinct group of genes that stood out was a set of previously characterized genotoxic-responsive genes such as ATF-3, GADD45b and JunB. These three genes were not found to be induced by Consistent with this hypothesis that MG88 action at 48 h is independent of DNA methylation is the fact that the genes induced by the DNA demethylating agent 5-azaCdR (MAGEB2 and SSX2) were not induced by MG88 treatment for 48h (Fig. 8) .
DISCUSSION
Multiple mechanisms regulate expression of DNMT1 within a cell (8) (7) (11) (32).
In this paper we address the question of whether mammalian cells possess a mechanism to respond to a sudden loss of DNMT1 and protect themselves from a global loss of DNA methylation during replication in the absence of DNMT1. It is well established that genotoxic challenges such as DNA damage evoke distinct cellular responses resulting in a transient intra S phase arrest in DNA replication (20) (21) (22) . This intra S phase arrest guards against build-up of mutations during DNA replication before the other checkpoints at G2/M and G1/S could take effect.
Similarly, relying on G2/M and G1/S checkpoints to respond to the absence of DNMT1 in the fork during replication could result in a significant loss of DNA methylation and a build-up of epigenomic errors.
We demonstrate here that following DNMT1 knock down, cells found in the S phase of the cell cycle are partitioned into two groups, those that incorporate BrdU and those that do not incorporate BrdU (Fig. 3) . Our data is consistent with the presence of an intra S phase checkpoint that arrests all the replication forks in a cell, as illustrated by the appearance of a group of cells in S that do not incorporate any BrdU as a response to a reduction in availability of DNMT1.
Different origins of replication replicate at discreet and well defined positions in the cell cycle. Origins that replicate early in the cell cycle are associated with genomic regions that are hypomethylated and are actively transcribed (52), while origins that replicate late in S are associated with inactive genes, which are also known to be hypermethylated (53) . The results presented in Fig. 3 and Fig.6 show that DNA replication is arrested at any point in the S phase of the cell cycle. This is inconsistent with the hypothesis that DNMT1 knockdown affects only specific classes of origins.
What is the signal that triggers a stress response to antisense DNMT1 knockdown? It is possible that the emergence of demethylated DNA caused by replication in the absence of DNMT1 triggers the intra S phase arrest. Alternatively, the signal is the inhibition of de novo synthesis of DNMT1 leading to its absence from DNA replication factories. The fact that 5-azaCdR, which causes a far more extensive demethylation than MG88, does not trigger the same magnitude of intra S phase arrest of replication (Fig. 3) , suggests that it is not the demethylation that triggers the intra S phase arrest. Rather, our data is consistent with the hypothesis that it is the reduction in DNMT1 protein that triggers the intra S phase arrest observed after MG88 treatment.
We propose that the intra S phase arrest guarantees that no DNA is synthesized in the absence of DNMT1. However, this is a transient and incomplete protection and delayed demethylation is observed following extended MG88 treatment (Fig. 6 ). 5-aza-CdR bypasses this checkpoint to a large extent since it does not reduce DNMT1 synthesis but traps DNMT1 only once the replication fork has formed in the presence of DNMT1.
These differences in the mechanisms of action of these two inhibitors have important implications on the design and therapeutic utility of different DNA methylation inhibitors (31) . Agents such as MG88, that reduce the availability of DNMT1 at the replication fork, are strong inhibitors of cell growth and should be effective in inhibiting tumor growth but will not cause extensive demethylation (33) . There might be an advantage for therapeutic agents that do not cause extensive demethylation since extensive hypomethylation has been previously associated with metastasis (54) and possibly induction of silenced repetitive elements (55, 56) . The data presented in Table 1 illustrates the risks inherent in using DNA demethylating agents. In addition to induction of antimitotic and proapoptotic genes, 5-aza-CdR induces 3 families of testis/cancer specific antigens that were previously implicated in tumor progression and potentially tumor invasion and metastasis. It is interesting to note that expression of GAGE antigen family has been associated with poor prognosis in some cancers. G antigen 7 is expressed in prostate cancer (43) and G antigen 7c was proposed to be an antiapoptotic gene (57) . Similarly, MAGE expression is associated with metastasis (53, 54) . SSX2 was shown to be expressed in a wide variety of tumors (50) and was identified as one of 13 antigens that react exclusively with sera from colon cancer patients but not with sera from normal patients (58) .
In addition to the change in cell kinetics, the cells respond to DNMT1 knock down by a change in the gene expression program. A significant fraction of the induced genes is known to be involved in genotoxic stress responses (Table 2) . We have previously proposed that DNMT1 controls the expression of certain genes by a direct repression function that does not involve DNA methylation (18) . DNMT1 was previously shown to interact with HDAC1 (59), HDAC2 (60) and Rb-E2F1 (61). We propose that some of the early genes induced by DNMT1 knock down are similarly controlled by the DNA methylation independent gene repression activities of DNMT1.
by guest on August 17, 2017 http://www.jbc.org/ It remains to be seen whether the genes induced by DNMT1 knockdown are also involved in the intra S phase arrest or whether they are parallel responses that augment the protection against epigenomic loss. Recent studies have identified some of the players involved in the intra-S-phase checkpoint in response to ionizing DNA damage. ATM is activated by ionizing radiation, which in turn activates two signaling pathways, one leading to inactivation of cdk2 and intra S phase arrest, and the other leading to activation of p21 and G1 arrest (35) . We have previously shown Although the precise mechanism by which reduction of DNMT1 causes intra S phase arrest is unknown, our data describes a new class of putative checkpoints that react to epigenomic stress caused by reduction of DNMT1 levels. We propose that this mechanism has evolved to protect the genome from unscheduled demethylation and to maintain the coordination of replication of the genome and the epigenome.
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